azomethane has been researched along with Hepatic Encephalopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baine, AM; Chen, F; Gardner, LB; Hori, T; Nguyen, JH; Uemoto, S | 1 |
1 other study(ies) available for azomethane and Hepatic Encephalopathy
| Article | Year |
|---|---|
Fulminant liver failure models with subsequent encephalopathy in the mouse.
Topics: Animals; Azo Compounds; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Prognosis; Survival Rate; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |